Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database

Surgery

Volumn 142, Issue 3, 2007, Pages 426-427

  Payen, Didier ^a   Sundin, David P ^b   Nelson, David R ^b   Williams, Mark D ^b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN;

ABDOMINAL INFECTION; BLEEDING; CONFIDENCE INTERVAL; DATA BASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; LUNG INFECTION; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL PATIENT;

ANTI-INFECTIVE AGENTS; DATABASES; HUMANS; MULTIVARIATE ANALYSIS; ODDS RATIO; POSTOPERATIVE HEMORRHAGE; PROTEIN C; RECOMBINANT PROTEINS; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 34548179034     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.04.004     Document Type: Letter

References (1)

1. Payen D., Sablotzki A., Barie P.S., Ramsay G., Lowry S., Williams M., et al. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort. Surgery 140 (2006) 726-739